Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002871 (
anemia
)
52,094
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The function of the Fanconi
anemia
complementation group A (FANCA) protein remains unclear. To investigate possible protein-protein interactions, we performed yeast two-hybrid screening using a FANCA fragment as bait.
Sorting nexin 5
(
SNX5
), a new member of the human SNX family, was identified as a putative FANCA-binding protein. The interaction between FANCA and
SNX5
was confirmed by immunoprecipitation studies. All members of the SNX family have a characteristic amino acid region termed the phox homology (PX) domain. Deletion mutant analysis indicated that the PX domain is not required for binding to FANCA. The SNX proteins are thought to play an important role in receptor trafficking between organelles. We found that overexpression of
SNX5
increased FANCA protein levels. Northern blot analysis of
SNX5
showed the presence of alternatively spliced transcripts and different expression patterns in various human cancer cell lines and normal tissues. Further studies are needed to elucidate the functional significance of FANCA and
SNX5
binding; however, we speculate that FANCA may affect
SNX5
traffic with cell surface receptors.
...
PMID:SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein. 1060 Apr 72